NewsMarkets

Health

LSD Trial Success Paves Way for US Anxiety Approval by 2027

Definium Therapeutics reports its investigational LSD tablet met primary endpoints in a phase III trial, potentially leading to regulatory approval in the United States within two years.

2 publishers · 2 articles · first seen 15 Sept 2026 · updated 3h ago

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. LSD Drug's Anxiety Win; Alanis Morissette's 'Psychosis'; ADHD and GI Issues MedPageToday.com - medical news for physicians
  2. LSD could be approved for anxiety in the US in 2027 New Scientist

In this story